-
HIV Drugs Market to Exceed US $41.55 Billion by 2029, with 3.3% CAGR: The Business Research Company
10 Dec 2025 10:30 GMT
… the HIV drug market. HIV/AIDS … Emcure Pharmaceuticals
• Micro Labs Limited
• Northeast Pharmaceutical Group … treatment.
Comparative Analysis Of Leading HIV Drugs Market Segments
The hiv drugs … EFV), Nevirapine (NVP), Etravirine (ETR), Rilpivirine ( …
-
Drug Resistance Among Newly Diagnosed People Living with HIV-1 in Sichuan, China: A Large-Scale Population-Based Cross-Sectional Study
24 Nov 2025 15:45 GMT
… drugs, including NNRTIs such asdoravirine(DOR), efavirenz(EFV), etravirine … Medications and Drug … HIV Transmission Networks Monitoring and Intervention(2021 Trial … HIV antiviral drug treatment manual (2023 edition)” officially released. national center for AIDS …
-
Switching to Doravirine Maintains Viral Suppression in HIV-1
18 Nov 2025 12:37 GMT
… patients with HIV-1 infection, switching from etravirine-containing antiretroviral … change in ART), treatment discontinuations due to … minimal potential for drug-drug interactions make it … advisory fees from various pharmaceutical companies including Gilead, …
-
Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options
22 Oct 2025 10:38 GMT
… mouth, for example a medicine taken by mouth.
… drug resistance, poor adherence to an HIV treatment regimen or interrupting treatment. … mutations to doravirine and etravirine (both non-nucleoside reverse … resistance in the clinical trials, only three developed …
-
India to rewrite drug-quality rulebook to match US, EU, Japan standards
24 Sep 2025 17:48 GMT
… Indian-made medicines and help grow the country’s pharmaceutical market. The … Etravirine tablets; antibiotics, including Cefprozil and Cefuroxime Axetil; and antituberculosis drugs … of substandard drugs.
Harshad Lalwani, founder of Hummsa Biotech, views IP …
-
Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study
22 Jul 2025 17:06 GMT
… to the drug treatment at different … drugs are known and FDA approved inhibitors of HIV … Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences and Department of Biotechnology … , dolutegravir, and etravirine against main protease …
-
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
08 Jul 2025 10:53 GMT
… trials evaluating the safety and tolerability of weekly ulonivirine and drug … medications for the treatment of HIV- … 1 infection is not recommended.
Coadministration of PIFELTRO with efavirenz, etravirine … impact of pharmaceutical industry regulation …
-
Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China
22 May 2025 15:03 GMT
… and GEMINI-2 (NCT02831764) trials,28,29 with data … analysis of antiretroviral drugs for treatment-naive HIV infection in China … r) and/or etravirine (ETR), is well tolerated … Institute of Medicine Economics. Menet - China pharmaceutical information database …
-
Impact of HIV Pretreatment Drug Resistance on Secondary Transmission Through Treatment Dropout: A Prospective Population-Based Study in Southwestern China
06 May 2025 08:21 GMT
… 2023 National Free HIV Antiviral Treatment Drug Treatment Manual incorporated Etravirine into the first … the HPTN 071 (PopART) trial in South Africa. PLoS One … AIDS Antiviral Drug Treatment Manual. Beijing: People’s Medical Publishing House; 2007.
48. HIV drug …
-
Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48
12 Mar 2025 15:40 GMT
… clinical development and chief medical officer, Merck Research … HIV-1 infection is not recommended.
Coadministration of PIFELTRO with efavirenz, etravirine … for the treatment of HIV-1. Trials with islatravir … the impact of pharmaceutical industry regulation and …
About
© 1995-2025